Influence of Obesity and Insulin Resistance on the Reproductive Outcome of Iraqi Women Undergoing Intracytoplasmic Sperm Injection

Sundus Ali Dawood; Hayder Ali Lafta Mossa; Mufeeda Ali Jwad

doi:10.54133/ajms.v6i1.580

Authors

Sundus Ali Dawood High Institute for Infertility Diagnosis and Assisted Reproductive Technologies, Al-Nahrain University-Baghdad-Iraq. https://orcid.org/0009-0008-5156-2456
Hayder Ali Lafta Mossa High Institute for Infertility Diagnosis and Assisted Reproductive Technologies, Al-Nahrain University, Baghdad, Iraq
Mufeeda Ali Jwad High Institute for Infertility Diagnosis and Assisted Reproductive Technologies, Al-Nahrain University, Baghdad, Iraq https://orcid.org/0000-0002-7995-6755

DOI:

https://doi.org/10.54133/ajms.v6i1.580

Keywords:

HOMA-IR, Insulin resistance, ICSI, Obesity

Abstract

Background: Insulin resistance (IR) is commonly associated with obesity, which plays a role in the pathogenesis of reproductive disorders. Objectives: To evaluate the impact of insulin resistance and obesity on ICSI outcomes in Iraqi infertile females. Methods: Ninety women who were unable to conceive received an intracytoplasmic sperm injection and have various infertility causes; Age range: 18–40 participated in this prospective clinical cross-sectional study. Three groups of patients were formed based on their body mass index (BMI) rankings. The ovarian hyperstimulation antagonist protocol was administered to all women. Serum glucose, insulin and HOMA-IR were measured for all participants on the ovum pickup day. In addition, the results of ICSI were determined. Results: The insulin levels and HOMA-IR were significantly higher in obese females than in overweight and normal weight groups. There was significantly lower BMI, waist/hip ratio, and HOMA-IR in pregnant females when compared with non-pregnant ladies. There is a significant negative correlation between fasting insulin, HOMA-IR with metaphase II oocytes, maturation rate, grade 1 embryos and pregnancy outcome. The cutoff values of fasting serum insulin and HOMA-IR levels were ≤ 4.64 (ng/ml) and ≤ 1.1, respectively, as predictors of positive pregnancy in women undergoing ICSI. Conclusions: Insulin resistance impairs the ICSI outcomes of infertile women. Furthermore, obesity may increase the risk of insulin resistance in infertile women; therefore, enhancing HOMA-IR and BMI will positively impact ICSI outcomes.

Downloads

Download data is not yet available.

References

Rahman MS, Hossain KS, Das S, Kundu S, Adegoke EO, Rahman MA, et al. Role of insulin in health and disease: An update. Int J Mol Sci. 2021;22(12):1-19. doi: 10.3390/ijms22126403.

Lee SH, Park SY, Choi CS. Insulin resistance: From mechanisms to therapeutic strategies. Diabetes Metab J. 2022;46(1):15-37. doi: 10.4093/dmj.2021.0280.

Wang H, Zhang Y, Fang X, Kwak-Kim J, Wu L. Insulin resistance adversely affect IVF outcomes in lean women without PCOS. Front Endocrinol (Lausanne). 2021;12:734638. doi: 10.3389/fendo.2021.734638.

Mohsin HAH, Mossa HAL, Jawad MA. The impact of serum and follicular fluid secreted frizzled-related protein-5 on ICSI outcome in Iraqi infertile women with different body mass index. Biomedicine. 2023;43(4):1239-1246. doi: 10.51248/.v43i4.3109.

Broughton DE, Moley KH. Obesity and female infertility: potential mediators of obesity’s impact. Fertil Steril. 2017;107(4):840-847. doi: 10.1016/j.fertnstert.2017.01.017.

Ahmed B, Sultana R, Greene MW. Adipose tissue and insulin resistance in obese. Biomed Pharmacother. 2021;137:111315. doi: 10.1016/j.biopha.2021.111315.

World Health Organization (WHO). Waist Circumference and waist–hip ratio. Report of a WHO expert consultation. Geneva, 8-11 December 2008:8–11. Available from: http://www.who.int

Hasan HA, Selman MO, Jwad MA. Effect of body mass index on serum CA125 level in females with PCOS. Iraqi J Embryos Infertil Res. 2020;10(1):101-118.

Yong W, Wang J, Leng Y, Li L, Wang H. Role of obesity in female reproduction. Int J Med Sci. 2023;20(3):366. doi: 10.7150/ijms.80189.

Zatterale F, Longo M, Naderi J, Raciti GA, Desiderio A, Miele C, et al. Chronic adipose tissue inflammation linking obesity to insulin resistance and type 2 diabetes. Front Physiol. 2020;10:1-20. doi: 10.3389/fphys.2019.01607.

Brown M, Dainty S, Strudwick N, Mihai AD, Watson JN, Dendooven R, et al. Endoplasmic reticulum stress causes insulin resistance by inhibiting delivery of newly synthesized insulin receptors to the cell surface. Mol Biol Cell. 2020;31(23):2597-2629. doi: 10.1091/mbc.E18-01-0013.

Wan Y, Muhammad T, Huang T, Lv Y, Sha Q, Yang S, et al. IGF2 reduces meiotic defects in oocytes from obese mice and improves embryonic developmental competency. Reprod Biol Endocrinol. 2022;20(1):1-13. doi: 10.1186/s12958-022-00972-9.

Paley CA, Johnson MI. Abdominal obesity and metabolic syndrome: Exercise as medicine? BMC Sports Sci Med Rehabil. 2018;10(1):1-8. doi: 10.1186/s13102-018-0097-1.

Yang T, Yang Y, Zhang Q, Liu D, Liu N, Li Y, et al. Homeostatic model assessment for insulin resistance is associated with late miscarriage in non-dyslipidemic women undergoing fresh IVF/ICSI embryo transfer. Front Endocrinol (Lausanne). 2022;13:1-11. doi: 10.3389/fendo.2022.880518.

Silvestris E, de Pergola G, Rosania R, Loverro G. Obesity as disruptor of the female fertility. Reprod Biol Endocrinol. 2018;16(1). doi: 10.1186/s12958-018-0336-z.

Hussam F, Khudair SA, Alkhafaje WK, Alnassar YS, Kaoud RM, Abed AN, et al. A Cross-sectional study regarding infertility among women in Iraq. J Obstet Gynecol Cancer Res. 2023;8(1):47-52.

World Obesity Federation. Obesity Classification. 2022 [cited 2023 Sep 18]. Available from: https://www.worldobesity.org/about/about-obesity/obesity-classification

Balaban B, Brison D, Calderón G, Catt J, Conaghan J, Cowan L, et al. The Istanbul consensus workshop on embryo assessment: proceedings of an expert meeting. Hum Reprod. 2011;26(6):1270-1283. doi: 10.1093/humrep/der037.

Zhang Y, Li Z, Ren B, Wu W, Liu Y, Wang X, et al. Diagnostic value of a single β-hCG test in predicting reproductive outcomes in women undergoing cleavage embryo transfer: A retrospective analysis from a single center. Reprod Health. 2020;19:145. doi: 10.1186/s12978-022-01455-1.

Jain M, Singh M, (Eds.), Assisted Reproductive Technology (ART) Techniques, StatPearls Publishing; 2022. PMID: 35015434.

Nelson OE, Chukwuma EF. Association of body mass index with hypothalamus-pituitary-ovarian axis hormones in infertile women in the Niger Delta region, Nigeria. Open J Obstet Gynecol. 2022;12(08):671-685. doi: 10.4236/ojog.2022.128060.

Pengpid S, Peltzer K. Overweight and obesity among adults in Iraq: Prevalence and correlates from a national survey in 2015. Int J Environ Res Public Health. 2021;18(8):4198. doi: 10.3390/ijerph18084198.

Al-Yasiry RZ, Jwad MA, Hasan MF, Alsayigh HA. How obesity affects female fertility. Med J Babylon. 2022;19(2):111-114. doi: 10.4103/MJBL.MJBL_8_22.

Abd Ali A, Al-Hilli N, Jawad MA. Effect of obesity on ICSI outcome in Iraqi infertile females. Biochem Cell Arch. 2020;20(2):6383-6389.

Marinelli S, Napoletano G, Straccamore M, Basile G. Female obesity and infertility: outcomes and regulatory guidance. Acta Biomed. 2022;93(4):e2022278. doi: 10.23750/abm.v93i4.13466.

Ribeiro LM, Sasaki LMP, Silva AA, Souza ES, Oliveira Lyrio A, C M G Figueiredo A, et al. Overweight, obesity and assisted reproduction: A systematic review and meta-analysis. Eur J Obstet Gynecol Reprod Biol. 2022;271:117-127. doi: 10.1016/j.ejogrb.2022.01.019.

Fedorcsák P, Dale PO, Storeng R, Tanbo T, Åbyholm T. The impact of obesity and insulin resistance on the outcome of IVF or ICSI in women with polycystic ovarian syndrome. Hum Reprod. 2001;16(6):1086-1091. doi: 10.1093/humrep/16.6.1086.

Páez JCS, Arreseygor VG, Zgrablich P. Obesity and the possibility of conceiving a child during assisted reproduction treatment: An Argentinian experience. JBRA Assist Reprod. 2020;24(2):115. doi: 10.5935/1518-0557.20190064.

Dornelles VC, Hentschke MR, Badalotti M, Telöken IB, Trindade VD, Cunegatto B, et al. The impact of body mass index on laboratory, clinical outcomes and treatment costs in assisted reproduction: a retrospective cohort study. BMC Womens Health. 2022;22(1):479. doi: 10.1186/s12905-022-02036-x.

Ozekinci M, Seven A, Olgan S, Sakinci M, Keskin U, Akar ME, et al. Does obesity have detrimental effects on IVF treatment outcomes? BMC Womens Health. 2015;15:61. doi: 10.1186/s12905-015-0223-0.

Zeng R, Chen H, Zeng X, Qin L. The essential role of body weight in adjusting Gn dosage to prevent high ovarian response for women with PCOS during IVF: A retrospective study. Front Endocrinol (Lausanne). 2022;13:922044. doi: 10.3389/fendo.2022.922044.

Pandey S, Pandey S, Maheshwari A, Bhattacharya S. The impact of female obesity on the outcome of fertility treatment. J Hum Reprod Sci. 2010;3(2):62-67. doi: 10.4103/0974-1208.69332.

Hu D, Huang B, Xiong M, Yao J, Yang S, Wu R, et al. Impact of elevated body mass index on cumulative live birth rate and obstetric safety in women undergoing assisted reproductive technology. Sci Rep. 2022;12(1):18858. doi: 10.1038/s41598-022-23576-0.

Kumar M, Kaushik D, Kaur J, Proestos C, Oz F, Oz E, et al. A critical review on obesity: Herbal approach, bioactive compounds, and their mechanism. Appl Sci. 2022;12(16). doi: 10.3390/app12168342.

Leary C, Leese HJ, Sturmey RG. Human embryos from overweight and obese women display phenotypic and metabolic abnormalities. Hum Reprod. 2015;30(1):122-132. doi: 10.1093/humrep/deu276.

Comstock IA, Kim S, Behr B, Lathi RB. Increased body mass index negatively impacts blastocyst formation rate in normal responders undergoing in vitro fertilization. J Assist Reprod Genet. 2015;32(9):1299-1304. doi: 10.1007/s10815-015-0515-1.

Herrero J, Tejera A, Albert C, Vidal C, de los Santos MJ, Meseguer M. A time to look back: analysis of morphokinetic characteristics of human embryo development. Fertil Steril. 2013;100(6):1602-1609. doi: 10.1016/j.fertnstert.2013.08.033.

Keefe DL. Telomeres and genomic instability during early development. Eur J Med Genet. 2020;63(2):103638. doi: 10.1016/j.ejmg.2019.03.002.

Bosch E, Broer S, Griesinger G, Grynberg M, Humaidan P, Kolibianakis E, et al. ESHRE guideline: ovarian stimulation for IVF/ICSI†. Hum Reprod Open. 2020;2020(2):hoaa009. doi: 10.1093/hropen/hoaa009.

Pan XM, Lin Z, Li N, Wu JQ, Chen DQ, Zhu YM, et al. Effects of body mass index on the outcomes of in vitro fertilization in Chinese patients with polycystic ovary syndrome: a retrospective cohort study. J Zhejiang Univ Sci B. 2018;19(6):490-496. doi: 10.1631/jzus.B1800113.

Abdul Kareem NG, Jafer AK, Mahmood WT, Alkabban M. Evaluation of insulin resistance according to the obesity grades in Iraqi non-diabetic adults. Biochem Cell Arch. 2020;20(1):2157-2162.

Song H, Yu Z, Li P, Wang Y, Shi Y. HOMA-IR for predicting clinical pregnancy rate during IVF. Gynecol Endocrinol. 2022;38(1):33-38. doi: 10.1080/09513590.2021.1952976.

Raperport C, Chronopoulou E, Homburg R. Effects of metformin treatment on pregnancy outcomes in patients with polycystic ovary syndrome. Expert Rev Endocrinol Metab. 2021;16(2):37-47. doi: 10.1080/17446651.2021.1889366.

Ke J, Feng Y, Chen Z. Association between waist circumference and female infertility in the United States. PLoS One. 2023;18(12):e0295360. doi: 10.1371/journal.pone.0295360.

Khalaf Allah A, Elmekkawi S, Megahed A. Obesity index that better predict ovarian response: Body mass index, waist circumference, waist hip ratio, or waist height ratio in women undergoing ICSI: A pilot study. Evid Based Women’s Health J. 2020;10(1):54-64. doi: 10.21608/ebwhj.2019.18167.1040.